MPC Polymer Coated Artificial Heart Valves

Prosthetic mechanical heart valves for aortic and mitral valve replacement in cardiac surgery. These devices utilize advanced materials for durability and long-term hemodynamic performance.

Porcine aortic valve bioprosthesis for heart valve replacement and repair procedures. This xenograft valve is chemically modified using proprietary animal tissue engineering technology to enhance biocompatibility and durability. Indicated for patients requiring surgical or interventional aortic valve replacement, particularly those with congenital or degenerative valve disease.

Biomimetic coating for prosthetic heart valves to prevent thromboembolism. Improves hemocompatibility and reduces need for anticoagulation.

Bovine pericardial heart valves for cardiac valve replacement and repair procedures. These bioprosthetic valves utilize chemically modified animal tissue to provide hemodynamic performance in patients requiring surgical or interventional treatment of native or prosthetic valve disease.

Mechanical heart valve prosthesis for aortic and mitral valve replacement in cardiac surgery. Durable long-term solution for patients requiring valve repair.

Multi-API nanogel coating for prosthetic heart valves combining antimicrobial and antithrombotic properties. The ultra-thin coating prevents infective endocarditis and reduces thromboembolic events while maintaining valve hemodynamics.

Artificial valve device for replacement of diseased native heart valves. Engineered for hemodynamic performance and long-term durability in cardiac operations.

Heparin-based coating systems where heparin is covalently bound to device surfaces to directly inhibit thrombin cascade and reduce fibrin deposition at blood-device interfaces. Designed for prolonged and permanent blood-contacting applications including embolic protection devices, heart valves, vascular access systems, flow diverters, venous stents, left atrial appendage devices, and intracranial stents. Backed by long-established clinical and regulatory history across multiple device categories.

A transcatheter intracardiac device designed to treat severe mitral and tricuspid valve regurgitation without open-heart surgery. The device provides a minimally invasive solution for correcting leaky heart valves.

Biological Heart Valve Prosthesis with valve leaflets made of bovine pericardium that is preserved, sterilized and cross-linked with ethylene glycol diglycidyl ether. The biological material demonstrates resilience to calcium uptake and durability for long-term clinical performance. It features a compound stent combining polypropylene and superelastic shape-memory alloy for structural stability and adaptive fit within native anatomy.

Specialized coating system for cardiovascular implants and interventional devices including stents and catheters. Improves biocompatibility and prevents thrombus formation in blood-contacting applications.

Prosthetic heart valve with leaflets made from bovine pericardium, preserved and cross-linked with ethylene glycol diglycidyl ether to resist calcium uptake and ensure long-term clinical durability.